Option Care Health financials
$22.81−0.39%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.44B | $1.35B | $1.47B | $1.44B | $1.42B | $1.33B | $1.35B | $1.28B | $1.23B | $1.15B | $1.12B | $1.09B |
| Gross profit | $267.3M | $262.0M | $282.9M | $272.9M | $269.0M | $263.1M | $268.4M | $256.7M | $249.4M | $238.5M | $247.1M | $254.3M |
| Gross margin | 18.5% | 19.4% | 19.3% | 19.0% | 19.0% | 19.7% | 19.9% | 20.1% | 20.3% | 20.8% | 22.0% | 23.3% |
| Operating income | $85.1M | $72.5M | $91.5M | $84.5M | $82.7M | $79.2M | $87.0M | $85.1M | $80.7M | $69.0M | $84.6M | $81.0M |
| Net income | $53.9M | $45.3M | $58.5M | $51.8M | $50.5M | $46.7M | $60.1M | $53.9M | $53.0M | $44.8M | $57.2M | $56.3M |
| Net margin | 3.7% | 3.4% | 4.0% | 3.6% | 3.6% | 3.5% | 4.5% | 4.2% | 4.3% | 3.9% | 5.1% | 5.2% |
| Diluted EPS | $0.35 | $0.29 | $0.37 | $0.32 | $0.31 | $0.28 | $0.35 | $0.31 | $0.30 | $0.26 | $0.32 | $0.31 |
| EBITDA | $103.5M | $88.2M | $111.8M | $101.6M | $99.7M | $95.6M | $104.5M | $100.3M | $96.2M | $84.3M | $84.6M | $96.7M |
| Operating cash flow | $183.6M | -$12.1M | $35.9M | $139.4M | $90.3M | -$7.2M | $36.1M | $160.4M | $195.7M | -$68.8M | $51.0M | $61.0M |
| Free cash flow | $172.5M | -$21.2M | $22.2M | $130.2M | $81.2M | -$16.6M | $25.8M | $150.7M | $185.9M | -$74.6M | $31.1M | $52.6M |
| Diluted shares | 153.5M | 158.2M | 159.4M | 163.1M | 164.1M | 166.8M | 169.7M | 171.9M | 174.1M | 175.6M | 177.0M | 180.5M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $193.8M | $177.3M | $232.6M | $309.8M | $198.8M | $171.4M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $1.16B | $1.16B | $1.16B | $1.16B | $1.11B | $1.11B |
| Total assets | $3.38B | $3.38B | $3.46B | $3.48B | $3.38B | $3.31B |
| Total liabilities | $2.12B | $2.03B | $2.13B | $2.12B | $2.02B | $1.96B |
| Shareholders' equity | $1.26B | $1.35B | $1.33B | $1.36B | $1.36B | $1.35B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology